GlassScriptPhysician profile
Matthew B Troshinsky
NPI 1205886116
$1,273.89
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $755 · 2020: $57.85 · 2021: $26.36 · 2022: $12.19 · 2023: $402 · 2024: $20.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $282.02 | 2019-2024 | Xifaxan, Plenvu |
| Abbvie INC. | $268.08 | 2019-2023 | Linzess, Rinvoq, Viberzi |
| Takeda Pharmaceuticals U.S.A., INC. | $245.95 | 2019-2023 | Entyvio |
| Pfizer INC. | $122.51 | 2019 | |
| Gilead Sciences, INC. | $72.13 | 2019-2023 | |
| Janssen Biotech, INC. | $50.02 | 2019-2023 | Simponi Aria, Simponi, Stelara |
| Braintree Laboratories, INC. | $38.47 | 2023 | Sutab |
| Boston Scientific Corporation | $26.87 | 2022-2023 | Captivator II |
| Intercept Pharmaceuticals, INC. | $24.98 | 2023 | Ocaliva |
| Celgene Corporation | $22.25 | 2023 | Zeposia |
| Enterra Medical, INC. | $19.80 | 2023 | |
| Shionogi INC | $19.72 | 2019 | |
| Echosens North America, INC. | $15.68 | 2019 | |
| Genzyme Corporation | $15.20 | 2023 | |
| Shire North American Group INC | $12.83 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $12.76 | 2023 | Ibsrela |
| Ironwood Pharmaceuticals, INC | $12.74 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Troshinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.